| Revenue Growth | Total revenue $345 million, up 15% year-over-year; capitated revenue up 18%. |
|---|---|
| Mgmt Confidence | High confidence citing 'durable foundation' and three consecutive profitable quarters. |
| Demand Visibility | Strong demand from 60 mid-sized Medicare Advantage plans for P3's model. |
| Order Book | At-risk membership at 105,000; 28,000 lives in management services pipeline. |
| Margin Trends | Medical margin $44 million; 90.6% MLR adjusted for prior period items. |
| Op. Leverage | Growth in existing markets adds membership at low incremental cost. |
| Pricing Power | Improved payer economics and 18% increase in capitated revenue per member. |
| Vol vs Price | Growth driven by 18% rate progression and improved payer economics. |
| Segment Growth | Nebraska market launch in May 2026 serving as new growth model. |
| New Clients | Added 23 clinicians to P3 Restore; expanding delegated functions with payers. |
| Capex & Debt | Actively managing liquidity; cash and equivalents at $61 million. |
| Regulatory | Recognized $7 million favorable medical margin from 2025 CMS-ACO reconciliation. |
| Commentary | Focusing on 'margin first, membership growth after' to ensure sustainable economics. |
| New Launches | Launched Nebraska market; implementing utilization management and senior wellness centers. |
Growth
Revenue rose 15% to $345 million; Adjusted EBITDA reached $21 million in Q3.
Outlook
Raised 2026 Adjusted EBITDA guidance to $90M-$110M; identified $200M potential value creation.
Risks
Management pivoted to vague 'multi-year' language when pressed for specific 2027 enrollment numbers.
The company's earnings call, NASDAQ: PIII, and its 8-K filed with the SEC. Summary written with AI assistance from the call.
Earnings call webcast ↗ Watch on YouTube ↗
P3 Health Partners Inc.: key numbers
- Share price
- $2.41Close, Nov 16
- Sector
- Industrial Applications and Services
- Industry
- Services-Health ServicesSIC 8000
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from P3 Health Partners Inc.
All →P3 Health Partners Q3 2026 Results: Turns Profitable, Net Income $15.6M
P3 Health Partners Inc. reported its third quarter 2026 results, highlighting significant risks regarding its ability to continue as a going concern and the need for additional capital. The company continues to experience net losses and faces challenges maintaining compliance with debt covenants and Nasdaq listing requirements.
- Key figure
- Net income $15.6M
P3 Health Partners Financial Results
P3 Health Partners reported Q3 2026 financial results with revenue of $396 million, up 15% year-over-year, and net income of $30.8 million. The company raised its full-year 2026 Adjusted EBITDA guidance midpoint to $100 million based on strong year-to-date performance and improved network economics.
- Term
- Q3 2026
“This was another strong quarter for P3. The foundation we have built over the past two years is showing up both in the care our patients receive and in the consistency of our results. We carry real momentum into 2027, as evidenced by our medical cost trend, and I am excited about what lies ahead for our patients, our providers, and our partners.”
Dr. Aric Coffman, CEO of P3